Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice.

Opeolu Ojo, DK Srinivasan, BO Owolabi, JM Conlon, Peter Flatt, Yasser Abdel-Wahab

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


AbstractBACKGROUND: Magainin-AM2, a previously described amphibian host-defense peptide, stimulates insulin- and glucagon-like peptide-1-release in vitro. This study investigated anti-diabetic effects of the peptide in mice with diet-induced obesity and glucose intolerance.METHODS: Male National Institute of Health Swiss mice were maintained on a high-fat diet for 12-weeks prior to the daily treatment with magainin-AM2. Various indices of glucose tolerance were monitored together with insulin secretory responsiveness of islets at conclusion of study.RESULTS: Following twice daily treatment with magainin-AM2 for 15days, no significant difference in body weight and food intake was observed compared with saline-treated high fat control animals. However, non-fasting blood glucose was significantly (P
Original languageEnglish
Pages (from-to)80-87
JournalBiochim Biophys Acta
Issue number1
Publication statusPublished (in print/issue) - 20 Oct 2014


Dive into the research topics of 'Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice.'. Together they form a unique fingerprint.

Cite this